Evelo Biosciences, Inc.
Evelo Biosciences, Inc. (EVLO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVLO · as of Jun 8, 2026
Key Statistics
Explore Evelo Biosciences, Inc. Data
evlo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 62.5%
Competitors & Peers
evlo competitorsEVLO
ARDS
BTAX
HSTC
ICCT
INFIQStock Performance
Full HistoryAbout Evelo Biosciences, Inc.
Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases. Its pipeline includes EDP18…
what is evelo biosciences, inc. · evlo stock overview · evelo biosciences, inc. company profile · who is evelo biosciences, inc. ceo · evlo OTC · evelo biosciences, inc. headquarters · evelo biosciences, inc. business segments
About Stock Overview & Key Data
Evelo Biosciences, Inc. (EVLO) is a Healthcare company in the Biotechnology industry, listed on OTC since May 8, 2018. As of the latest trading session, EVLO stock price is $0.00, with a market capitalization of $1,898. The stock has returned -80.00% over the past 12 months and -80.00% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Evelo Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Evelo Biosciences, Inc. reported revenue of — and net income of -$114.5M. For detailed data — including Evelo Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evelo Biosciences, Inc. (EVLO) stock price is $0.00. The stock is traded on OTC under the ticker symbol EVLO. The 52-week range is $0.00 – $0.00.